Article
Unleash AI's potential
Measuring the return from pharmaceutical innovation 2024
Our report series Measuring the return from pharmaceutical innovation has provided insights into the productivity of biopharma R&D since 2010. We have expanded our analysis over time and our data set now covers the top 20 companies by 2020 R&D spend.
Find out more